Gyneos® Highlighted for Its Role in Women’s Cognitive Aging and Metabolic Resilience

Recent scientific coverage highlights Gyneos® (D-chiro-inositol) as a novel nutraceutical approach addressing metabolic dysfunction and cognitive aging in women. Based on preclinical research in female models of Alzheimer’s disease, the article explores how D-chiro-inositol restores insulin signaling, reduces tau pathology, modulates neuroinflammation, and supports cognitive performance, particularly in post-menopausal conditions.

The publication positions Gyneos® as a gender-specific innovation in women’s health, integrating metabolic resilience, hormonal balance, and brain health into a unified nutraceutical strategy for healthy aging and long-term cognitive wellbeing.